Drug Discovery Services Market Size, Share, Trends, Industry Analysis Report : By Process, Type (Chemistry Services and Biology Services), Drug Type, Therapeutic Area, End User, and Region

Description

List of Tables

The drug discovery services market size is expected to reach USD 75.13 billion by 2034, according to a new study by Polaris Market Research. The report "Drug Discovery Services Market Size, Share, Trends, Industry Analysis Report: By Process, Type (Chemistry Services and Biology Services), Drug Type, Therapeutic Area, End User, and Region - Market Forecast, 2026-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Drug discovery services are the research and development services offered to pharmaceutical, biotech, and life science companies to help discover new drug candidates. The services offered span different aspects of drug development, including target identification, lead discovery, hit-to-lead optimization, preclinical development, and candidate validation. The main objective of drug discovery services is to discover new potential therapeutic compounds and optimize them before entering clinical trials.

The market for drug discovery services is growing rapidly due to several factors, including the rising complexity of drug development, the growing prevalence of chronic diseases, and the increasing need for novel drugs. One of the major trends in the drug discovery services market is the outsourcing of research work to contract research organizations (CROs). This is because it allows pharmaceutical and biotechnology companies to reduce costs and accelerate drug development.

Lead optimization is the foremost growing segment of the drug discovery service market. This expansion is attributed to the rising emphasis on optimizing drug leads to increase their potency and safety before embarking on clinical trials. Additionally, the target selection segment remains the leader due to its paramount importance in selecting the best drug target during the initial stages of drug development.

Chemistry services currently dominate the market and provide an important support function in drug synthesis and early biological data. Biology services are also projected to grow at the highest rate because biological knowledge plays an important role in the development of biologics and personalized medicine.

Pharmaceutical and biotech companies lead the market. This is because they are heavily investing in research to develop drugs and treatments. Also, the educational institutes category is expanding rapidly as more partnerships are formed among prominent market players.

New technologies, including artificial intelligence, machine learning, and gene editing techniques such as CRISPR, are revolutionizing drug development. They are making it possible to identify potential drug molecules quickly and easily. Opportunities exist in the growing fields of personalized medicine, biologics, and gene therapies. Collaborations, the growing interest in new therapeutic areas, and the need for high-quality customized solutions in the drug development process also fuel the drug discovery services market.

Where Is the Market Headed?

More companies have started outsourcing to access specialized platforms such as high-throughput screening, advanced cell models, and bioinformatics. Outsourcing is helping companies accelerate discovery timelines and run multiple programs at the same time. North America currently leads the drug discovery services market, mainly due to a strong pharmaceutical industry and technological developments. Asia Pacific is expected to be the fastest-growing region, driven mainly by investments in infrastructure development and the growing number of countries outsourcing drug discovery services.

What Does Drug Discovery Services Report Reveals?

What is the global market size and CAGR for the market during 2026-2034?

Which factors are contributing to the industry expansion?

Who are the key industry players? What is their relative position in terms of competitive positioning?

How do different service types, such as chemistry services and biology services, influence the market landscape?

How does the market differ in terms of process, type, drug type, therapeutic area, end user, and geography? Which is the leading end user?

What are the opportunities in different regional markets, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?

What are the emerging technologies and innovations in the market?

Polaris Market Research has segmented the drug discovery services market on the basis of process, type, drug type, therapeutic area, end user, and region:

By Process Outlook (Revenue, USD Billion, 2021-2034)

Target Selection

Target Validation

Hit-To-Lead Identification

Lead Optimization

Candidate Validation

By Type Outlook (Revenue, USD Billion, 2021-2034)

Chemistry Services

Biology Services

By Drug Type Outlook (Revenue, USD Billion, 2021-2034)

Small Molecules

Biologics

By Therapeutic Area Outlook (Revenue, USD Billion, 2021-2034)

Oncology

Infectious Diseases

Cardiovascular Diseases

Neurological Diseases

Immunological Diseases

Digestive & Gastrointestinal Diseases

Genitourinary & Women's Health

Respiratory Diseases

Endocrine & Metabolic Diseases

Other Therapeutic Areas

By End User Outlook (Revenue, USD Billion, 2021-2034)

Pharmaceutical & Biotechnology Companies

Academic Institutes

Others

By Regional Outlook (Revenue, USD Billion, 2021-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM3920

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Drug Discovery Services Market Insights

4.1. Drug Discovery Services Market - Therapeutic Area Snapshot
4.2. Drug Discovery Services Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Demand for Outsourcing Research Activities
  - 4.2.1.2. Rising Prevalence of Chronic Diseases
  - 4.2.1.3. Advancements in Technology and Personalized Medicine
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Drug Discovery Services Market Therapeutic Area Trends
4.6. Value Chain Analysis

5. Global Drug Discovery Services Market, by Process

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
5.3. Target Selection
- 5.3.1. Global Drug Discovery Services Market, by Target Selection, by Region, 2021-2034 (USD Billion)
5.4. Target Validation
- 5.4.1. Global Drug Discovery Services Market, by Target Validation, by Region, 2021-2034 (USD Billion)
5.5. Hit-To-Lead Identification
- 5.5.1. Global Drug Discovery Services Market, by Hit-To-Lead Identification, by Region, 2021-2034 (USD Billion)
5.6. Lead Optimization
- 5.6.1. Global Drug Discovery Services Market, by Lead Optimization, by Region, 2021-2034 (USD Billion)
5.7. Candidate Validation
- 5.7.1. Global Drug Discovery Services Market, by Candidate Validation, by Region, 2021-2034 (USD Billion)

6. Global Drug Discovery Services Market, by Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
6.3. Chemistry Services
- 6.3.1. Global Drug Discovery Services Market, by Chemistry Services, by Region, 2021-2034 (USD Billion)
6.4. Biology Services
- 6.4.1. Global Drug Discovery Services Market, by Biology Services, by Region, 2021-2034 (USD Billion)

7. Global Drug Discovery Services Market, by Drug Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
7.3. Small Molecules
- 7.3.1. Global Drug Discovery Services Market, by Small Molecules, by Region, 2021-2034 (USD Billion)
7.4. Biologics
- 7.4.1. Global Drug Discovery Services Market, by Biologics, by Region, 2021-2034 (USD Billion)

8. Global Drug Discovery Services Market, by Therapeutic Area

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
8.3. Oncology
- 8.3.1. Global Drug Discovery Services Market, by Oncology, by Region, 2021-2034 (USD Billion)
8.4. Infectious Diseases
- 8.4.1. Global Drug Discovery Services Market, by Infectious Diseases, by Region, 2021-2034 (USD Billion)
8.5. Cardiovascular Diseases
- 8.5.1. Global Drug Discovery Services Market, by Cardiovascular Diseases, by Region, 2021-2034 (USD Billion)
8.6. Neurological Diseases
- 8.6.1. Global Drug Discovery Services Market, by Neurological Diseases, by Region, 2021-2034 (USD Billion)
8.7. Immunological Diseases
- 8.7.1. Global Drug Discovery Services Market, by Immunological Diseases, by Region, 2021-2034 (USD Billion)
8.8. Digestive & Gastrointestinal Diseases
- 8.8.1. Global Drug Discovery Services Market, by Digestive & Gastrointestinal Diseases, by Region, 2021-2034 (USD Billion)
8.9. Genitourinary & Women's Health
- 8.9.1. Global Drug Discovery Services Market, by Genitourinary & Women's Health, by Region, 2021-2034 (USD Billion)
8.10. Respiratory Diseases
- 8.10.1. Global Drug Discovery Services Market, by Respiratory Diseases, by Region, 2021-2034 (USD Billion)
8.11. Endocrine & Metabolic Diseases
- 8.11.1. Global Drug Discovery Services Market, by Endocrine & Metabolic Diseases, by Region, 2021-2034 (USD Billion)
8.12. Other Therapeutic Areas
- 8.12.1. Global Drug Discovery Services Market, by Other Therapeutic Areas, by Region, 2021-2034 (USD Billion)

9. Global Drug Discovery Services Market, by End User

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
9.3. Pharmaceutical & Biotechnology Companies
- 9.3.1. Global Drug Discovery Services Market, by Pharmaceutical & Biotechnology Companies, by Region, 2021-2034 (USD Billion)
9.4. Academic Institutes
- 9.4.1. Global Drug Discovery Services Market, by Academic Institutes, by Region, 2021-2034 (USD Billion)
9.5. Others
- 9.5.1. Global Drug Discovery Services Market, by Others, by Region, 2021-2034 (USD Billion)

10. Global Drug Discovery Services Market, by Geography

10.1. Key Findings
10.2. Introduction
- 10.2.1. Drug Discovery Services Market Assessment, By Geography, 2021-2034 (USD Billion)
10.3. Drug Discovery Services Market - North America
- 10.3.1. North America: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
- 10.3.2. North America: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
- 10.3.3. North America: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
- 10.3.4. North America: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.3.5. North America: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.3.6. Drug Discovery Services Market - U.S.
  - 10.3.6.1. U.S.: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.3.6.2. U.S.: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.3.6.3. U.S.: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.3.6.4. U.S.: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.3.6.5. U.S.: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.3.7. Drug Discovery Services Market - Canada
  - 10.3.7.1. Canada: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.3.7.2. Canada: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.3.7.3. Canada: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.3.7.4. Canada: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.3.7.5. Canada: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
10.4. Drug Discovery Services Market - Europe
- 10.4.1. Europe: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
- 10.4.2. Europe: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
- 10.4.3. Europe: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
- 10.4.4. Europe: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.4.5. Europe: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.4.6. Drug Discovery Services Market - UK
  - 10.4.6.1. UK: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.4.6.2. UK: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.4.6.3. UK: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.4.6.4. UK: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.6.5. UK: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.4.7. Drug Discovery Services Market - France
  - 10.4.7.1. France: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.4.7.2. France: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.4.7.3. France: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.4.7.4. France: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.7.5. France: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.4.8. Drug Discovery Services Market - Germany
  - 10.4.8.1. Germany: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.4.8.2. Germany: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.4.8.3. Germany: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.4.8.4. Germany: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.8.5. Germany: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.4.9. Drug Discovery Services Market - Italy
  - 10.4.9.1. Italy: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.4.9.2. Italy: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.4.9.3. Italy: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.4.9.4. Italy: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.9.5. Italy: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.4.10. Drug Discovery Services Market - Spain
  - 10.4.10.1. Spain: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.4.10.2. Spain: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.4.10.3. Spain: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.4.10.4. Spain: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.10.5. Spain: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.4.11. Drug Discovery Services Market - Netherlands
  - 10.4.11.1. Netherlands: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.4.11.2. Netherlands: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.4.11.3. Netherlands: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.4.11.4. Netherlands: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.11.5. Netherlands: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.4.12. Drug Discovery Services Market - Russia
  - 10.4.12.1. Russia: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.4.12.2. Russia: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.4.12.3. Russia: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.4.12.4. Russia: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.12.5. Russia: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.4.13. Drug Discovery Services Market - Rest of Europe
  - 10.4.13.1. Rest of Europe: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.4.13.2. Rest of Europe: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.4.13.3. Rest of Europe: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.4.13.4. Rest of Europe: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.4.13.5. Rest of Europe: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
10.5. Drug Discovery Services Market - Asia Pacific
- 10.5.1. Asia Pacific: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
- 10.5.2. Asia Pacific: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
- 10.5.3. Asia Pacific: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
- 10.5.4. Asia Pacific: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.5.5. Asia Pacific: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.5.6. Drug Discovery Services Market - China
  - 10.5.6.1. China: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.5.6.2. China: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.5.6.3. China: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.5.6.4. China: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.6.5. China: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.5.7. Drug Discovery Services Market - India
  - 10.5.7.1. India: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.5.7.2. India: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.5.7.3. India: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.5.7.4. India: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.7.5. India: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.5.8. Drug Discovery Services Market - Malaysia
  - 10.5.8.1. Malaysia: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.5.8.2. Malaysia: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.5.8.3. Malaysia: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.5.8.4. Malaysia: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.8.5. Malaysia: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.5.9. Drug Discovery Services Market - Japan
  - 10.5.9.1. Japan: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.5.9.2. Japan: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.5.9.3. Japan: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.5.9.4. Japan: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.9.5. Japan: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.5.10. Drug Discovery Services Market - Indonesia
  - 10.5.10.1. Indonesia: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.5.10.2. Indonesia: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.5.10.3. Indonesia: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.5.10.4. Indonesia: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.10.5. Indonesia: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.5.11. Drug Discovery Services Market - South Korea
  - 10.5.11.1. South Korea: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.5.11.2. South Korea: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.5.11.3. South Korea: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.5.11.4. South Korea: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.11.5. South Korea: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.5.12. Drug Discovery Services Market - Australia
  - 10.5.12.1. Australia: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.5.12.2. Australia: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.5.12.3. Australia: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.5.12.4. Australia: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.12.5. Australia: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.5.13. Drug Discovery Services Market - Rest of Asia Pacific
  - 10.5.13.1. Rest of Asia Pacific: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.5.13.2. Rest of Asia Pacific: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.5.13.3. Rest of Asia Pacific: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.5.13.4. Rest of Asia Pacific: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.5.13.5. Rest of Asia Pacific: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
10.6. Drug Discovery Services Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
- 10.6.2. Middle East & Africa: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
- 10.6.3. Middle East & Africa: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
- 10.6.4. Middle East & Africa: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.6.5. Middle East & Africa: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.6.6. Drug Discovery Services Market - Saudi Arabia
  - 10.6.6.1. Saudi Arabia: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.6.6.2. Saudi Arabia: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.6.6.3. Saudi Arabia: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.6.6.4. Saudi Arabia: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.6.5. Saudi Arabia: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.6.7. Drug Discovery Services Market - UAE
  - 10.6.7.1. UAE: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.6.7.2. UAE: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.6.7.3. UAE: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.6.7.4. UAE: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.7.5. UAE: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.6.8. Drug Discovery Services Market - Israel
  - 10.6.8.1. Israel: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.6.8.2. Israel: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.6.8.3. Israel: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.6.8.4. Israel: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.8.5. Israel: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.6.9. Drug Discovery Services Market - South Africa
  - 10.6.9.1. South Africa: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.6.9.2. South Africa: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.6.9.3. South Africa: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.6.9.4. South Africa: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.9.5. South Africa: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.6.10. Drug Discovery Services Market - Rest of Middle East & Africa
  - 10.6.10.1. Rest of Middle East & Africa: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.6.10.2. Rest of Middle East & Africa: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.6.10.3. Rest of Middle East & Africa: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.6.10.4. Rest of Middle East & Africa: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.6.10.5. Rest of Middle East & Africa: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
10.7. Drug Discovery Services Market - Latin America
- 10.7.1. Latin America: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
- 10.7.2. Latin America: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
- 10.7.3. Latin America: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
- 10.7.4. Latin America: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 10.7.5. Latin America: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.7.6. Drug Discovery Services Market - Mexico
  - 10.7.6.1. Mexico: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.7.6.2. Mexico: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.7.6.3. Mexico: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.7.6.4. Mexico: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.7.6.5. Mexico: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.7.7. Drug Discovery Services Market - Brazil
  - 10.7.7.1. Brazil: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.7.7.2. Brazil: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.7.7.3. Brazil: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.7.7.4. Brazil: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.7.7.5. Brazil: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.7.8. Drug Discovery Services Market - Argentina
  - 10.7.8.1. Argentina: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.7.8.2. Argentina: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.7.8.3. Argentina: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.7.8.4. Argentina: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.7.8.5. Argentina: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)
- 10.7.9. Drug Discovery Services Market - Rest of Latin America
  - 10.7.9.1. Rest of Latin America: Drug Discovery Services Market, by Process, 2021-2034 (USD Billion)
  - 10.7.9.2. Rest of Latin America: Drug Discovery Services Market, by Type, 2021-2034 (USD Billion)
  - 10.7.9.3. Rest of Latin America: Drug Discovery Services Market, by Drug Type, 2021-2034 (USD Billion)
  - 10.7.9.4. Rest of Latin America: Drug Discovery Services Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 10.7.9.5. Rest of Latin America: Drug Discovery Services Market, by End User, 2021-2034 (USD Billion)

11. Competitive Landscape

11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

12.1. Charles River Laboratories International, Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
12.2. Covance Inc. (part of Labcorp)
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
12.3. ICON plc
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
12.4. Syngene International Ltd.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
12.5. WuXi AppTec Co., Ltd.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
12.6. Pharmaceutical Product Development, LLC (PPD, part of Thermo Fisher Scientific)
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
12.7. Eurofins Scientific
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
12.8. GVK Biosciences
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
12.9. GVK Biosciences
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
12.10. Jubilant Biosys
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
12.11. Evotec SE
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
12.12. Medpace Holdings, Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
12.13. TCG Lifesciences
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development
12.14. Pharmaron Beijing Co., Ltd.
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Benchmarking
- 12.14.4. Recent Development\
12.15. Frontage Laboratories, Inc.
- 12.15.1. Company Overview
- 12.15.2. Financial Performance
- 12.15.3. Product Benchmarking
- 12.15.4. Recent Development
12.16. Selvita S.A.
- 12.16.1. Company Overview
- 12.16.2. Financial Performance
- 12.16.3. Product Benchmarking
- 12.16.4. Recent Development